Signal transduction in prostate cancer progression
- 22 March 2005
- journal article
- review article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 108 (4), 293-308
- https://doi.org/10.1042/cs20040329
Abstract
Prostate cancer is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths in the United States. When prostate cancer initially presents in the clinic, the tumour is dependent on androgen for growth and, therefore, responsive to the surgical or pharmacological ablation of circulating androgens. However, there is a high rate of treatment failure because the disease often recurs as androgen-independent metastases. Surprisingly, this late-stage androgen-independent prostate cancer almost always retains expression of the AR (androgen receptor), despite the near absence of circulating androgens. Although late-stage prostate cancer is androgen-independent, the AR still seems to play a role in cancer cell growth at this stage of disease. Therefore a key to understanding hormone-independent prostate cancer is to determine the mechanism(s) by which the AR can function even in the absence of physiological levels of circulating androgen. This review will focus on the role of growth factor signalling in prostate cancer progression to androgen independence and thus outline potential molecular areas of intervention to treat prostate cancer progression.Keywords
This publication has 106 references indexed in Scilit:
- Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart SizeScience Signaling, 2011
- Homeostasis in the breast: It takes a villageCancer Cell, 2004
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Androgen receptor gene amplification and protein expression in hormone refractory prostate cancerBritish Journal of Cancer, 2003
- RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor SuppressorJournal of Biological Chemistry, 2003
- Does Rap1 deserve a bad Rap?Trends in Biochemical Sciences, 2003
- Recombinant Expression and Purification of Human Androgen Receptor in a Baculovirus SystemBiochemical and Biophysical Research Communications, 2001
- The Hallmarks of CancerCell, 2000
- Localization of Epidermal Growth Factor-stimulated Ras/Raf-1 Interaction to Caveolae MembranePublished by Elsevier BV ,1996